Clinical Trial

Novel Imaging Techniques for the Characterization of Musculoskeletal Tumors II

Study acronym: TUMOSTEO II
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 21, 2020 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims at evaluating the value of various artificial intelligence based techniques to improve the characterization and image post-processing for patients with musculoskeletal tumors.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2020-05-15.
Status change: Not Yet Recruiting → Recruiting 2020-07-20
Trial Details
NCT Number NCT04394052
Lead Sponsor Central Hospital, Nancy, France
Collaborators: Lorraine Cancer Institute - ICL, Emille Gallé Surgical Center - CCEG, Diagnostic and Interventional Adaptative Imaging Laboratory - IADI
Conditions Soft Tissue Neoplasm, Bone Neoplasm
Enrollment 740 participants
Start Date 2020-06-01
Primary Completion 2026-06-01 (estimated)
Study Completion 2030-06-01 (estimated)
Updated on ClinicalTrials.gov 2020-07-21